Creatine for women in pregnancy for neuroprotection of the fetus (Q24187191)

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Proposed definition and classification of cerebral palsy, April 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Neuroprotective effects of creatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Creatine supplementation lowers brain glutamate levels in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Epidemiology of cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Pathophysiology of an hypoxic-ischemic insult during the perinatal period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Maternal dietary creatine supplementation does not alter the capacity for creatine synthesis in the newborn spiny mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Long-term developmental outcome of asphyxiated term neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Perinatal brain injury in the preterm and term newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Creatine pretreatment prevents birth asphyxia-induced injury of the newborn spiny mouse kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

How should randomised trials including multiple pregnancies be analysed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Maternal creatine: does it reach the fetus and improve survival after an acute hypoxic episode in the spiny mouse (Acomys cahirinus)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

A maternal diet supplemented with creatine from mid-pregnancy protects the newborn spiny mouse brain from birth hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Perinatal brain damage--from pathophysiology to prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Novel treatments after experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

White matter damage and intraventricular hemorrhage in very preterm infants: the EPIPAGE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Direct antioxidant properties of creatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Antenatal magnesium sulphate neuroprotection in the preterm infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

A systematic review of risk factors for cerebral palsy in children born at term in developed countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Magnesium sulphate for women at term for neuroprotection of the fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Clinical prognostic messages from a systematic review on cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Creatine for amyotrophic lateral sclerosis/motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Improved reperfusion and neuroprotection by creatine in a mouse model of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

The biological basis of injury and neuroprotection in the fetal and neonatal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Prevention of traumatic headache, dizziness and fatigue with creatine administration. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Perinatal brain injury: from pathogenesis to neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

The creatine kinase system and pleiotropic effects of creatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Creatine for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Melatonin for women in pregnancy for neuroprotection of the fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Chorioamnionitis and cerebral palsy in term and near-term infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Creatine supplementation does not impair kidney function in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2

Dietary supplement creatine protects against traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010846.PUB2